As of 2025-05-15, the Relative Valuation of Cue Biopharma Inc (CUE) is (10.78) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.75 USD, the upside of Cue Biopharma Inc based on Relative Valuation is -1547.1%.
The range of the Relative Valuation is (9.21) - (11.76) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 15.7x - 21.8x | 18.8x |
| Forward P/E multiples | 17.1x - 25.3x | 21.2x |
| Fair Price | (9.21) - (11.76) | (10.78) |
| Upside | -1335.9% - -1677.9% | -1547.1% |
| Date | P/E |
| 2025-05-13 | -1.42 |
| 2025-05-12 | -1.39 |
| 2025-05-09 | -1.44 |
| 2025-05-08 | -1.42 |
| 2025-05-07 | -1.42 |
| 2025-05-06 | -1.39 |
| 2025-05-05 | -1.44 |
| 2025-05-02 | -1.39 |
| 2025-05-01 | -1.39 |
| 2025-04-30 | -1.40 |
| 2025-04-29 | -1.42 |
| 2025-04-28 | -1.46 |
| 2025-04-25 | -1.45 |
| 2025-04-24 | -1.59 |
| 2025-04-23 | -1.55 |
| 2025-04-22 | -1.45 |
| 2025-04-21 | -1.45 |
| 2025-04-17 | -1.41 |
| 2025-04-16 | -1.44 |
| 2025-04-15 | -1.48 |
| 2025-04-14 | -1.47 |
| 2025-04-11 | -1.42 |
| 2025-04-10 | -1.33 |
| 2025-04-09 | -1.30 |
| 2025-04-08 | -1.14 |
| 2025-04-07 | -1.16 |
| 2025-04-04 | -1.25 |
| 2025-04-03 | -1.41 |
| 2025-04-02 | -1.46 |
| 2025-04-01 | -1.39 |
| 2025-03-31 | -1.69 |
| 2025-03-28 | -1.70 |
| 2025-03-27 | -1.85 |
| 2025-03-26 | -1.84 |
| 2025-03-25 | -1.85 |
| 2025-03-24 | -1.91 |
| 2025-03-21 | -1.82 |
| 2025-03-20 | -1.78 |
| 2025-03-19 | -1.80 |
| 2025-03-18 | -1.79 |
| 2025-03-17 | -1.76 |
| 2025-03-14 | -1.77 |
| 2025-03-13 | -1.80 |
| 2025-03-12 | -1.87 |
| 2025-03-11 | -1.93 |
| 2025-03-10 | -1.91 |
| 2025-03-07 | -2.04 |
| 2025-03-06 | -1.98 |
| 2025-03-05 | -2.07 |
| 2025-03-04 | -2.17 |